EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics

Kuan Liu, Huijing Chen, Yanhong Li, Bei Wang, Qian Li, Lu Zhang, Xiaohui Liu, Ce Wang, Yavuz Nuri Ertas, Hongyun Shi

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216867 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024. Verfasst von Kuan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Autophagy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 240 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy, a self-digestion mechanism, has emerged as a promising target in the realm of cancer therapy, particularly in bladder cancer (BCa), a urological malignancy characterized by dysregulated biological processes contributing to its progression. This highly conserved catabolic mechanism exhibits aberrant activation in pathological events, prominently featured in human cancers. The nuanced role of autophagy in cancer has been unveiled as a double-edged sword, capable of functioning as both a pro-survival and pro-death mechanism in a context-dependent manner. In BCa, dysregulation of autophagy intertwines with cell death mechanisms, wherein pro-survival autophagy impedes apoptosis and ferroptosis, while pro-death autophagy diminishes tumor cell survival. The impact of autophagy on BCa progression is multifaceted, influencing metastasis rates and engaging with the epithelial-mesenchymal transition (EMT) mechanism. Pharmacological modulation of autophagy emerges as a viable strategy to impede BCa progression and augment cell death. Notably, the introduction of nanoparticles for targeted autophagy regulation holds promise as an innovative approach in BCa suppression. This review underscores the intricate interplay of autophagy with cell death pathways and its therapeutic implications in the nuanced landscape of bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAutophagyHumansAntineoplastic AgentsEpithelial-Mesenchymal TransitionNanoparticlesApoptosisAnimalsFerroptosisCell Death

Stichwörter der Autor:innen

AutophagyBladder cancerCell death interactionsNanoparticlesNon-coding RNAs

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China.
  • Department of Gynecology, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China.
  • Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China. Electronic address: liuxiaohuia871120@163.com.
  • Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China. Electronic address: 15232261383@163.com.
  • Department of Biomedical Engineering, Erciyes University, Kayseri, 38039, Turkey; ERNAM-Nanotechnology Research and Application Center, Erciyes University, Kayseri, 38039, Turkey; UNAM-National Nanotechnology Research C…
  • Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, PR China. Electronic address: hyshi2015@163.com.

Zitieren

APA

Liu, K., Chen, H., Li, Y., Wang, B., Li, Q., Zhang, L., Liu, X., Wang, C., Ertas, Y. N., & Shi, H. (2024). Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216867

Vancouver

Liu K, Chen H, Li Y, Wang B, Li Q, Zhang L, et al. Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216867

BibTeX
@article{Liu2024,
  author = {Liu, Kuan and Chen, Huijing and Li, Yanhong and Wang, Bei and Li, Qian and Zhang, Lu and Liu, Xiaohui and Wang, Ce and Ertas, Yavuz Nuri and Shi, Hongyun},
  title = {Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216867}
}
Kostenlos starten →